Indo US Bio-Tech Adjusts Valuation Amid Strong Financial Performance and Market Sentiment Shift
Indo US Bio-Tech, a microcap in the Other Agricultural Products sector, has recently experienced a change in its evaluation, reflecting shifts in market sentiment. The company boasts strong financial metrics, including a high return on capital employed and low debt levels, despite underperforming against the broader market.
Indo US Bio-Tech, a microcap company in the Other Agricultural Products industry, has recently undergone an adjustment in its evaluation. This revision reflects a shift in the technical landscape surrounding the stock, indicating a change in market sentiment. The company has demonstrated notable financial metrics, including a high return on capital employed (ROCE) of 25.53%, showcasing its management efficiency. Additionally, Indo US Bio-Tech has maintained a low debt to EBITDA ratio of 0.80 times, highlighting its strong capacity to service debt. Over the last five quarters, the company has reported positive results, with a significant increase in profit after tax (PAT) of 127.10% and net sales growth of 58.43% in the latest six months.
Despite these positive indicators, the stock has underperformed relative to the broader market, with a one-year return of -52.57%, compared to a negative return of -2.87% for the BSE500 index. The stock is currently trading at a discount compared to its peers' average historical valuations, with a PEG ratio of 0.2, suggesting a fair valuation in light of its growth potential.
For more insights on Indo US Bio-Tech's performance, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
